サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：初代細胞の世界市場 - 規模、シェア、動向分析、機会、予測：由来別、タイプ別、エンドユーザー別、地域別（2019年～2029年）
市場調査レポート
商品コード
1249977

初代細胞の世界市場 - 規模、シェア、動向分析、機会、予測：由来別、タイプ別、エンドユーザー別、地域別（2019年～2029年）

Primary Cells Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Origin ; By Type ; By End User ; By Region
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 400 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
初代細胞の世界市場 - 規模、シェア、動向分析、機会、予測：由来別、タイプ別、エンドユーザー別、地域別（2019年～2029年）
出版日: 2023年03月21日
発行: Blueweave Consulting
ページ情報: 英文 400 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の初代細胞の市場規模は、2022年の42億9,000万米ドルから2029年までに86億米ドルに達し、2023年～2029年の予測期間中にCAGRで11.6%の大幅な成長が予測されています。市場の主な成長要因は、がんの発生率の増加、がん研究に対する政府の支援の拡大、医療業界を支えるインフラの拡大などです。

当レポートでは、世界の初代細胞市場について調査分析し、市場規模と予測、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の初代細胞市場の考察

  • 業界バリューチェーン分析
  • DROC分析
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 技術の進歩/最近の発展
  • 規制の枠組み
  • ポーターのファイブフォース分析

第4章 世界の初代細胞市場の概要

  • 市場規模と予測（2019年～2029年）
    • 金額
  • 市場シェアと予測
    • 由来別
      • ヒト初代細胞
      • 動物初代細胞
    • タイプ別
      • 造血細胞
      • 皮膚細胞
      • 消化管細胞
      • 肝細胞
      • その他（肺細胞、腎細胞、心臓細胞、筋骨格細胞、初代細胞）
    • エンドユーザー別
      • ライフサイエンス研究企業
      • 研究機関
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • ラテンアメリカ
      • 中東・アフリカ

第5章 北米の初代細胞市場

  • 市場規模と予測（2019年～2029年）
    • 金額
  • 市場シェアと予測
    • 由来別
    • タイプ別
    • エンドユーザー別
    • 国別
      • 米国
      • カナダ

第6章 欧州の初代細胞市場

  • 市場規模と予測（2019年～2029年）
    • 金額
  • 市場シェアと予測
    • 由来別
    • タイプ別
    • エンドユーザー別
    • 国別
      • ドイツ
      • 英国
      • イタリア
      • フランス
      • スペイン
      • ベルギー
      • ロシア
      • オランダ
      • その他の欧州

第7章 アジア太平洋の初代細胞市場

  • 市場規模と予測（2019年～2029年）
    • 金額
  • 市場シェアと予測
    • 由来別
    • タイプ別
    • エンドユーザー別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • オーストラリア・ニュージーランド
      • インドネシア
      • マレーシア
      • シンガポール
      • ベトナム
      • その他のアジア太平洋

第8章 ラテンアメリカの初代細胞市場

  • 市場規模と予測（2019年～2029年）
    • 金額
  • 市場シェアと予測
    • 由来別
    • タイプ別
    • エンドユーザー別
    • 国別
      • ブラジル
      • メキシコ
      • アルゼンチン
      • ペルー
      • その他のラテンアメリカ

第9章 中東・アフリカの初代細胞市場

  • 市場規模と予測（2019年～2029年）
    • 金額
  • 市場シェアと予測
    • 由来別
    • タイプ別
    • エンドユーザー別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • カタール
      • クウェート
      • 南アフリカ
      • ナイジェリア
      • アルジェリア
      • その他の中東・アフリカ

第10章 競合情勢

  • 主要企業とその製品のリスト
  • 世界の初代細胞企業の市場シェア分析（2022年）
  • 競合ベンチマーキング：経営パラメーター別
  • 主な戦略的展開（合併、買収、パートナーシップなど）

第11章 世界の初代細胞市場に対するCOVID-19の影響

第12章 企業プロファイル（企業の概要、財務マトリックス、競合情勢、主な人材、主な競合、連絡先、戦略的見通し、SWOT分析）

  • Thermo Fisher Scientific Inc
  • Merck Group
  • Lonza
  • Cell Biologics, Inc.
  • PromoCell-Human Centered Science
  • ZenBio, Inc.
  • STEMCELL Technologies Inc
  • AllCells
  • その他の著名な企業

第13章 主な戦略的推奨事項

第14章 調査手法

目次
Product Code: BWC23223

Global Primary Cells Market Size Doubles to Reach USD 8.6 Billion by 2029.

Global primary cells market is flourishing because of increasing adoption of technology advancements and growing cancer research and development.

BlueWeave Consulting, a leading strategic consulting and Market research firm, in its recent study, estimated global primary cells market size at USD 4.29 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global primary cells market size to grow at a significant CAGR of 11.6% reaching a value of USD 8.6 billion by 2029. Major growth factors of global primary cells market include an increasing incidence of cancer, growing government support for cancer research, and expanding infrastructure to support the healthcare industry. The growing prevalence of chronic diseases worldwide, such as cancer, infections, autoimmune disorders, diabetes, and cardiovascular diseases, is a significant contributor to the growth of the primary cell market. It has also led to a rise in research activities for advanced therapies. The use of primary cell cultures for drug screening and in-vitro testing is also becoming increasingly popular, contributing to the growth of the primary cell market. The global primary cells market is being driven by advancements in genetic engineering and increased funding for research into cellular treatments. However, concerns regarding primary cell culture contamination are anticipated to restrain the overall market growth during the period in analysis.

Global Primary Cells Market - Overview:

The primary cells market refers to the market for primary cells, which are cells that have been freshly isolated from living tissues or organs, typically from humans or animals. These cells are used for research purposes, including drug discovery and development, toxicology testing, and basic research. Primary cells are important tools for studying biological processes and diseases, and they are widely used in both academic and commercial research settings. The primary cells market includes the production, distribution, and sale of primary cells, as well as related products and services such as cell culture media, reagents, and cell isolation kits.

Impact of COVID-19 on Global Primary Cells Market

COVID-19 had a positive impact on primary cell market. Primary cell culture is being used by researchers to better understand the infection and build standardized epithelial cell culture models. These models can assist duplicate the features of the respiratory tract, perhaps leading to breakthrough scientific findings with medical applications. In addition, the identification of primary cells for the treatment of many diseases is expanding. Due to their increased use in a variety of healthcare applications, private associations, biotech businesses, and government agencies have increased their interest and investment in this area. The growing utilization of primary cell cultures for viral synthesis, which is then used to make numerous vaccines, is also projected to move the market ahead.

Global Primary Cells Market - By Region:

Global primary cells market covers five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America held the highest share of revenue in the primary cell culture market and this trend is expected to continue throughout the forecast period. The growth in the region's market can be attributed to factors such as the high cost of healthcare, the increasing elderly population, the rising prevalence of chronic illnesses, and government funding support. Furthermore, the market in the region is expanding due to the focus of market players on developing innovative cell culture applications, improved instrumentation, a wide range of cell types, and the study of their cellular interactions.

Competitive Landscape

Major players operating in global primary cells market include Thermo Fisher Scientific Inc, Merck Group, Lonza, Cell Biologics, Inc., PromoCell - Human Centered Science, ZenBio, Inc., STEMCELL Technologies Inc, and AllCells. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Primary Cells Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Global Primary Cells Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the Market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Primary Cells Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Cancer Research
      • 3.2.1.2. Advancement in Technologies
    • 3.2.2. Restraints
      • 3.2.2.1. Concern Regarding Primary Cell Culture Contamination
    • 3.2.3. Opportunities
      • 3.2.3.1. Advancing Biomedical Research Using Primary Cells in 3D Cultures
    • 3.2.4. Challenges
      • 3.2.4.1. Impact on Supply Chain Due to Covid
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Primary Cells Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Origin
      • 4.2.1.1. Human Primary Cells
      • 4.2.1.2. Animal Primary Cells
    • 4.2.2. By Type
      • 4.2.2.1. Hematopoietic Cells
      • 4.2.2.2. Dermatocytes
      • 4.2.2.3. Gastrointestinal Cells
      • 4.2.2.4. Hepatocytes
      • 4.2.2.4.1. Cryopreserved Hepatocytes
      • 4.2.2.4.2. Fresh Hepatocytes
      • 4.2.2.5. Others (Lung Cells, Renal Cells, Heat Cells, Musculoskeletal Cells, Primary Cells)
    • 4.2.3. By End User
      • 4.2.3.1. Life Science Research Companies
      • 4.2.3.2. Research Institutes
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Primary Cells Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Origin
    • 5.2.2. By Type
    • 5.2.3. By End User
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Origin
      • 5.2.4.1.2. By Type
      • 5.2.4.1.3. By End User
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Origin
      • 5.2.4.2.2. By Type
      • 5.2.4.2.3. By End User

6. Europe Primary Cells Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Origin
    • 6.2.2. By Type
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Origin
      • 6.2.4.1.2. By Type
      • 6.2.4.1.3. By End User
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Origin
      • 6.2.4.2.2. By Type
      • 6.2.4.2.3. By End User
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Origin
      • 6.2.4.3.2. By Type
      • 6.2.4.3.3. By End User
      • 6.2.4.4. France
      • 6.2.4.4.1. By Origin
      • 6.2.4.4.2. By Type
      • 6.2.4.4.3. By End User
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Origin
      • 6.2.4.5.2. By Type
      • 6.2.4.5.3. By End User
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Origin
      • 6.2.4.6.2. By Type
      • 6.2.4.6.3. By End User
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Origin
      • 6.2.4.7.2. By Type
      • 6.2.4.7.3. By End User
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Origin
      • 6.2.4.8.2. By Type
      • 6.2.4.8.3. By End User
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Origin
      • 6.2.4.9.2. By Type
      • 6.2.4.9.3. By End User

7. Asia-Pacific Primary Cells Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Origin
    • 7.2.2. By Type
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Origin
      • 7.2.4.1.2. By Type
      • 7.2.4.1.3. By End User
      • 7.2.4.2. India
      • 7.2.4.2.1. By Origin
      • 7.2.4.2.2. By Type
      • 7.2.4.2.3. By End User
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Origin
      • 7.2.4.3.2. By Type
      • 7.2.4.3.3. By End User
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Origin
      • 7.2.4.4.2. By Type
      • 7.2.4.4.3. By End User
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Origin
      • 7.2.4.5.2. By Type
      • 7.2.4.5.3. By End User
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Origin
      • 7.2.4.6.2. By Type
      • 7.2.4.6.3. By End User
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Origin
      • 7.2.4.7.2. By Type
      • 7.2.4.7.3. By End User
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Origin
      • 7.2.4.8.2. By Type
      • 7.2.4.8.3. By End User
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Origin
      • 7.2.4.9.2. By Type
      • 7.2.4.9.3. By End User
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Origin
      • 7.2.4.10.2. By Type
      • 7.2.4.10.3. By End User

8. Latin America Primary Cells Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Origin
    • 8.2.2. By Type
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Origin
      • 8.2.4.1.2. By Type
      • 8.2.4.1.3. By End User
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Origin
      • 8.2.4.2.2. By Type
      • 8.2.4.2.3. By End User
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Origin
      • 8.2.4.3.2. By Type
      • 8.2.4.3.3. By End User
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Origin
      • 8.2.4.4.2. By Type
      • 8.2.4.4.3. By End User
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Origin
      • 8.2.4.5.2. By Type
      • 8.2.4.5.3. By End User

9. Middle East & Africa Primary Cells Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Origin
    • 9.2.2. By Type
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Origin
      • 9.2.4.1.2. By Type
      • 9.2.4.1.3. By End User
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Origin
      • 9.2.4.2.2. By Type
      • 9.2.4.2.3. By End User
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Origin
      • 9.2.4.3.2. By Type
      • 9.2.4.3.3. By End User
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Origin
      • 9.2.4.4.2. By Type
      • 9.2.4.4.3. By End User
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Origin
      • 9.2.4.5.2. By Type
      • 9.2.4.5.3. By End User
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Origin
      • 9.2.4.6.2. By Type
      • 9.2.4.6.3. By End User
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Origin
      • 9.2.4.7.2. By Type
      • 9.2.4.7.3. By End User
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Origin
      • 9.2.4.8.2. By Type
      • 9.2.4.8.3. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Primary Cells Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Primary Cells Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Thermo Fisher Scientific Inc
  • 12.2. Merck Group
  • 12.3. Lonza
  • 12.4. Cell Biologics, Inc.
  • 12.5. PromoCell - Human Centered Science
  • 12.6. ZenBio, Inc.
  • 12.7. STEMCELL Technologies Inc
  • 12.8. AllCells
  • 12.9. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations